Cargando…
3D-GBS: a universal genotyping-by-sequencing approach for genomic selection and other high-throughput low-cost applications in species with small to medium-sized genomes
Despite the increased efficiency of sequencing technologies and the development of reduced-representation sequencing (RRS) approaches allowing high-throughput sequencing (HTS) of multiplexed samples, the per-sample genotyping cost remains the most limiting factor in the context of large-scale studie...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899395/ https://www.ncbi.nlm.nih.gov/pubmed/36740716 http://dx.doi.org/10.1186/s13007-023-00990-7 |
_version_ | 1784882627928391680 |
---|---|
author | de Ronne, Maxime Légaré, Gaétan Belzile, François Boyle, Brian Torkamaneh, Davoud |
author_facet | de Ronne, Maxime Légaré, Gaétan Belzile, François Boyle, Brian Torkamaneh, Davoud |
author_sort | de Ronne, Maxime |
collection | PubMed |
description | Despite the increased efficiency of sequencing technologies and the development of reduced-representation sequencing (RRS) approaches allowing high-throughput sequencing (HTS) of multiplexed samples, the per-sample genotyping cost remains the most limiting factor in the context of large-scale studies. For example, in the context of genomic selection (GS), breeders need genome-wide markers to predict the breeding value of large cohorts of progenies, requiring the genotyping of thousands candidates. Here, we introduce 3D-GBS, an optimized GBS procedure, to provide an ultra-high-throughput and ultra-low-cost genotyping solution for species with small to medium-sized genome and illustrate its use in soybean. Using a combination of three restriction enzymes (PstI/NsiI/MspI), the portion of the genome that is captured was reduced fourfold (compared to a “standard” ApeKI-based protocol) while reducing the number of markers by only 40%. By better focusing the sequencing effort on limited set of restriction fragments, fourfold more samples can be genotyped at the same minimal depth of coverage. This GBS protocol also resulted in a lower proportion of missing data and provided a more uniform distribution of SNPs across the genome. Moreover, we investigated the optimal number of reads per sample needed to obtain an adequate number of markers for GS and QTL mapping (500–1000 markers per biparental cross). This optimization allows sequencing costs to be decreased by ~ 92% and ~ 86% for GS and QTL mapping studies, respectively, compared to previously published work. Overall, 3D-GBS represents a unique and affordable solution for applications requiring extremely high-throughput genotyping where cost remains the most limiting factor. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13007-023-00990-7. |
format | Online Article Text |
id | pubmed-9899395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98993952023-02-06 3D-GBS: a universal genotyping-by-sequencing approach for genomic selection and other high-throughput low-cost applications in species with small to medium-sized genomes de Ronne, Maxime Légaré, Gaétan Belzile, François Boyle, Brian Torkamaneh, Davoud Plant Methods Methodology Despite the increased efficiency of sequencing technologies and the development of reduced-representation sequencing (RRS) approaches allowing high-throughput sequencing (HTS) of multiplexed samples, the per-sample genotyping cost remains the most limiting factor in the context of large-scale studies. For example, in the context of genomic selection (GS), breeders need genome-wide markers to predict the breeding value of large cohorts of progenies, requiring the genotyping of thousands candidates. Here, we introduce 3D-GBS, an optimized GBS procedure, to provide an ultra-high-throughput and ultra-low-cost genotyping solution for species with small to medium-sized genome and illustrate its use in soybean. Using a combination of three restriction enzymes (PstI/NsiI/MspI), the portion of the genome that is captured was reduced fourfold (compared to a “standard” ApeKI-based protocol) while reducing the number of markers by only 40%. By better focusing the sequencing effort on limited set of restriction fragments, fourfold more samples can be genotyped at the same minimal depth of coverage. This GBS protocol also resulted in a lower proportion of missing data and provided a more uniform distribution of SNPs across the genome. Moreover, we investigated the optimal number of reads per sample needed to obtain an adequate number of markers for GS and QTL mapping (500–1000 markers per biparental cross). This optimization allows sequencing costs to be decreased by ~ 92% and ~ 86% for GS and QTL mapping studies, respectively, compared to previously published work. Overall, 3D-GBS represents a unique and affordable solution for applications requiring extremely high-throughput genotyping where cost remains the most limiting factor. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13007-023-00990-7. BioMed Central 2023-02-05 /pmc/articles/PMC9899395/ /pubmed/36740716 http://dx.doi.org/10.1186/s13007-023-00990-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Methodology de Ronne, Maxime Légaré, Gaétan Belzile, François Boyle, Brian Torkamaneh, Davoud 3D-GBS: a universal genotyping-by-sequencing approach for genomic selection and other high-throughput low-cost applications in species with small to medium-sized genomes |
title | 3D-GBS: a universal genotyping-by-sequencing approach for genomic selection and other high-throughput low-cost applications in species with small to medium-sized genomes |
title_full | 3D-GBS: a universal genotyping-by-sequencing approach for genomic selection and other high-throughput low-cost applications in species with small to medium-sized genomes |
title_fullStr | 3D-GBS: a universal genotyping-by-sequencing approach for genomic selection and other high-throughput low-cost applications in species with small to medium-sized genomes |
title_full_unstemmed | 3D-GBS: a universal genotyping-by-sequencing approach for genomic selection and other high-throughput low-cost applications in species with small to medium-sized genomes |
title_short | 3D-GBS: a universal genotyping-by-sequencing approach for genomic selection and other high-throughput low-cost applications in species with small to medium-sized genomes |
title_sort | 3d-gbs: a universal genotyping-by-sequencing approach for genomic selection and other high-throughput low-cost applications in species with small to medium-sized genomes |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899395/ https://www.ncbi.nlm.nih.gov/pubmed/36740716 http://dx.doi.org/10.1186/s13007-023-00990-7 |
work_keys_str_mv | AT deronnemaxime 3dgbsauniversalgenotypingbysequencingapproachforgenomicselectionandotherhighthroughputlowcostapplicationsinspecieswithsmalltomediumsizedgenomes AT legaregaetan 3dgbsauniversalgenotypingbysequencingapproachforgenomicselectionandotherhighthroughputlowcostapplicationsinspecieswithsmalltomediumsizedgenomes AT belzilefrancois 3dgbsauniversalgenotypingbysequencingapproachforgenomicselectionandotherhighthroughputlowcostapplicationsinspecieswithsmalltomediumsizedgenomes AT boylebrian 3dgbsauniversalgenotypingbysequencingapproachforgenomicselectionandotherhighthroughputlowcostapplicationsinspecieswithsmalltomediumsizedgenomes AT torkamanehdavoud 3dgbsauniversalgenotypingbysequencingapproachforgenomicselectionandotherhighthroughputlowcostapplicationsinspecieswithsmalltomediumsizedgenomes |